コンシューマーヘルスケア市場：製品別、流通別-2025-2030年の世界予測

コンシューマーヘルスケア市場の2023年の市場規模は3,330億3,000万米ドルで、2024年には3,569億4,000万米ドルに達すると予測され、CAGR 7.38％で成長し、2030年には5,483億1,000万米ドルに達すると予測されています。

コンシューマーヘルスケアはヘルスケア産業の中で急速に発展している分野であり、消費者がセルフケアのために購入するウェルネス製品、OTC医薬品、栄養補助食品、パーソナルケアアイテムを包含しています。コンシューマーヘルスケアの必要性は、健康意識の高まり、慢性疾患の有病率の上昇、人口の高齢化、従来のヘルスケアサービスの負担を軽減するセルフメディケーションの動向によって推進されています。コンシューマーヘルスケア製品の用途は、予防医療、疾病管理、栄養補助食品、個人の健康管理など多岐にわたり、最終用途は便利な健康ソリューションを求める個人家庭や小売消費者です。主な成長要因としては、製品処方の技術的進歩、消費者のデジタルヘルスリテラシーの向上、ホリスティックな健康・ウェルネスアプローチへのシフトなどが挙げられます。デジタル・プラットフォームを活用した消費者への直接販売や個別化された健康ソリューションには機会が存在します。さらに、eコマース大手との戦略的提携による市場リーチの拡大や、消費者インサイトを強化するためのデータ分析への投資にも可能性があります。しかし、課題としては、規制のハードル、価格への敏感さ、ジェネリック医薬品やプライベートブランド医薬品との激しい競合などがあり、これらは成長の妨げになる可能性があります。また、企業は、消費者の信頼に影響を与える、オンライン健康スペースから生じる可能性のある誤った情報にも注意する必要があります。パーソナライズされた栄養、遠隔医療、AIを活用した健康モニタリングなどの分野でイノベーションを起こせば、競争上の優位性をもたらすことができます。また、環境への責任を求める消費者の声の高まりを受けて、持続可能で環境に優しい製品ラインを模索することもできます。市場力学はダイナミックで消費者中心であり、利便性とアクセシビリティがますます重視されています。消費者の嗜好や技術動向の変化に機敏に対応し続けることが、この急成長市場で持続的な成長と成功を収めるために不可欠です。新たな健康動向を先取りするための研究開発への投資や、消費者の信頼を築くための製品情報の透明性への取り組みなどが、調査から提言されています。

市場力学：急速に進化するコンシューマーヘルスケア市場の主要市場インサイトを公開

コンシューマーヘルスケア市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 老人人口の増加とセルフメディケーション製品に対する消費者の傾斜
  • 手頃な価格でヘルスケアへのアクセスを改善するための政府支援
  • プライベートブランド製品の採用拡大コンシューマーヘルスケア
• 市場抑制要因
  • 有効成分を欠く偽造品の入手可能性
• 市場機会
  • ウェルネス・予防医薬品の承認率の上昇
  • オンライン薬局の急成長とオンライン・プラットフォームによる入手性の向上
• 市場の課題
  • コンシューマーヘルスケア製品の乱用・誤用に関する懸念

ポーターの5つの力：コンシューマーヘルスケア市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、コンシューマーヘルスケア市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：コンシューマーヘルスケア市場における外部からの影響の把握

外部マクロ環境要因は、コンシューマーヘルスケア市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析コンシューマーヘルスケア市場における競合情勢の把握

コンシューマーヘルスケア市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスコンシューマーヘルスケア市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、コンシューマーヘルスケア市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨コンシューマーヘルスケア市場における成功への道筋を描く

コンシューマーヘルスケア市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢化人口の増加と消費者のセルフメディケーション製品への傾向
    • 手頃な価格で改善されたヘルスケアへのアクセスを提供するための政府の支援
    • プライベートラベルコンシューマーヘルスケア製品の採用増加
  • 抑制要因
    • 医薬品有効成分を含まない偽造品の流通
  • 機会
    • 健康・予防薬の承認率の向上
    • オンライン薬局の急速な成長とオンラインプラットフォームによる可用性の向上
  • 課題
    • コンシューマーヘルスケア製品の乱用や誤用に関する懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 コンシューマーヘルスケア市場：製品別

• 栄養補助食品
• 市販薬

第7章 コンシューマーヘルスケア市場配布元

• 百貨店
• 独立小売業者
• 薬局またはドラッグストア
• 専門小売業者
• スーパーマーケットまたはハイパーマーケット

第8章 南北アメリカのコンシューマーヘルスケア市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のコンシューマーヘルスケア市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのコンシューマーヘルスケア市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • SPEキャピタル、チュニジアの大手栄養補助食品会社Vitalの過半数株式を取得
  • ニュートリリティウスは、新しい栄養補助食品の発売によりポートフォリオを拡大し、食品科学と技術の力を解き放ちます。
  • LBB SpecialtiesとDSMが北米の栄養補助食品流通における提携を発表
  • コスモスヘルス、AmazonとeBayを通じてスカイプレミアムライフ栄養補助食品をドイツとオーストリアで発売へ
  • 健康サプリメント：タタ・コンシューマーが健康サプリメント分野に参入、植物性タンパク質パウダーを発売
  • シプラヘルス、栄養補助食品ブランド「エンデュラ・マス」を買収
  • Orkla HealthがHealthspanを買収
  • アムウェイ・インドがグミとゼリーストリップの栄養補助食品を発売
  • ウェルビーイング・ニュートリション、ファイアサイド・ベンチャーズの主導で220万米ドルを調達
  • バイエル、インドにコンシューマーヘルス部門を設立
• 戦略分析と提言

企業一覧

• Abbott Laboratories Inc.
• Alembic Pharmaceuticals Ltd.
• Alkem Laboratories Limited
• AMCO Proteins
• American Health Inc.
• Amway Corporation by Alticor corporation
• Axtria Inc.
• BASF SE
• Bayer AG
• Bionova Lifesciences by Pragati Biocare Pvt. Ltd.
• Boehringer Ingelheim International GmbH
• Cipla, Inc.
• Dr. Reddy's Laboratories
• Eli Lilly and Company
• Endo Pharmaceuticals PLC by DuPont de Nemours, Inc.
• Gemini Pharmaceuticals Inc.
• Glanbia PLC
• GlaxoSmithKline PLC
• Glenmark Pharmaceuticals Ltd.
• Henin Lukinz Pvt. Ltd.
• Herbalife Ltd.
• Hetero Drugs Ltd.
• Himalaya Wellness Company
• Iovate Health Sciences International Inc.
• Ipsen S.A.
• Johnson & Johnson Services, Inc.
• Koninklijke DSM N.V.
• Lonza Group Ltd.
• Lupin Limited
• Mankind Pharma
• MusclePharm Corporation
• Mylan Pharmaceuticals Pvt. Ltd. by Viatris
• Nature's Bounty, Inc. by Nestle S.A.
• Novartis AG
• Omega Protein Corporation
• Pfizer Inc.
• Piramal Group
• Procter & Gamble Company
• PureTek Corporation
• QuestNutrition
• Reckitt Benckiser Group PLC
• Sanofi S.A.
• Sun Pharmaceutical Industries Limited
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
• Ventus Pharmaceuticals Private Limited
• Zoic Biotech Private Limited

LIST OF FIGURES

• FIGURE 1. CONSUMER HEALTHCARE MARKET RESEARCH PROCESS
• FIGURE 2. CONSUMER HEALTHCARE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. CONSUMER HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. CONSUMER HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CONSUMER HEALTHCARE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CONSUMER HEALTHCARE MARKET DYNAMICS
• TABLE 7. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY OTC PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY DEPARTMENTAL STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY INDEPENDENT RETAILERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY PHARMACIES OR DRUGSTORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SPECIALIST RETAILERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CONSUMER HEALTHCARE MARKET SIZE, BY SUPERMARKETS OR HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 23. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. CANADA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 35. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. CHINA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 37. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. INDIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 72. ITALY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. ITALY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 80. POLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. POLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 82. QATAR CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. QATAR CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 102. CONSUMER HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 103. CONSUMER HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023

The Consumer Healthcare Market was valued at USD 333.03 billion in 2023, expected to reach USD 356.94 billion in 2024, and is projected to grow at a CAGR of 7.38%, to USD 548.31 billion by 2030.

Consumer healthcare is a rapidly evolving segment of the healthcare industry, encompassing wellness products, OTC drugs, dietary supplements, and personal care items that consumers purchase for self-care. The necessity for consumer healthcare is driven by the increasing health awareness, rising prevalence of chronic diseases, an aging population, and a trend towards self-medication which reduces the burden on traditional healthcare services. The application of consumer healthcare products spans across preventive care, disease management, nutritional supplementations, and personal wellness, with end-use in individual households and retail consumers seeking convenient health solutions. Key growth influencers include technological advancements in product formulations, increased digital health literacy among consumers, and a shift towards holistic health and wellness approaches. Opportunities exist in leveraging digital platforms for direct-to-consumer sales and personalized health solutions. Furthermore, there's potential in expanding market reach through strategic partnerships with e-commerce giants and investing in data analytics to enhance consumer insights. However, challenges include regulatory hurdles, price sensitivity, and intense competition from generic and private-label brands, which may hinder growth. Companies should also be wary of misinformation that can arise from online health spaces, affecting consumer trust. Innovating in areas such as personalized nutrition, telehealth, and AI-driven health monitoring can offer competitive advantages, as can exploring sustainable and eco-friendly product lines in response to growing consumer demand for environmental responsibility. The nature of the consumer healthcare market is dynamic and consumer-centric, with an increasing emphasis on convenience and accessibility. Staying agile and responsive to changing consumer preferences and technological trends will be critical for sustained growth and success in this burgeoning market. Recommendations include investing in research and development to stay ahead of emerging health trends and committing to transparency in product information to build consumer trust.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Consumer Healthcare Market

The Consumer Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising geriatric population and inclination of consumers towards self-medication products
  • Government support to offer affordable and improved access to healthcare
  • Growing adoption of private labels consumer healthcare products
• Market Restraints
  • Availability of counterfeit products that lack active pharmaceutical ingredients
• Market Opportunities
  • Increasing approval rate of wellness and preventive medicines
  • Rapid growth of online pharmacies and improved availability through online platforms
• Market Challenges
  • Concerns associated with abuse and misuse of consumer healthcare products

Porter's Five Forces: A Strategic Tool for Navigating the Consumer Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Consumer Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Consumer Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Consumer Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Consumer Healthcare Market

A detailed market share analysis in the Consumer Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Consumer Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Consumer Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Consumer Healthcare Market

A strategic analysis of the Consumer Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Consumer Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Limited, AMCO Proteins, American Health Inc., Amway Corporation by Alticor corporation, Axtria Inc., BASF SE, Bayer AG, Bionova Lifesciences by Pragati Biocare Pvt. Ltd., Boehringer Ingelheim International GmbH, Cipla, Inc., Dr. Reddy's Laboratories, Eli Lilly and Company, Endo Pharmaceuticals PLC by DuPont de Nemours, Inc., Gemini Pharmaceuticals Inc., Glanbia PLC, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Henin Lukinz Pvt. Ltd., Herbalife Ltd., Hetero Drugs Ltd., Himalaya Wellness Company, Iovate Health Sciences International Inc., Ipsen S.A., Johnson & Johnson Services, Inc., Koninklijke DSM N.V., Lonza Group Ltd., Lupin Limited, Mankind Pharma, MusclePharm Corporation, Mylan Pharmaceuticals Pvt. Ltd. by Viatris, Nature's Bounty, Inc. by Nestle S.A., Novartis AG, Omega Protein Corporation, Pfizer Inc., Piramal Group, Procter & Gamble Company, PureTek Corporation, QuestNutrition, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ventus Pharmaceuticals Private Limited, and Zoic Biotech Private Limited.

Market Segmentation & Coverage

This research report categorizes the Consumer Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Dietary Supplements and OTC Pharmaceuticals.
• Based on Distribution, market is studied across Departmental Stores, Independent Retailers, Pharmacies or Drugstores, Specialist Retailers, and Supermarkets or Hypermarkets.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising geriatric population and inclination of consumers towards self-medication products
    • 5.1.1.2. Government support to offer affordable and improved access to healthcare
    • 5.1.1.3. Growing adoption of private labels consumer healthcare products
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of counterfeit products that lack active pharmaceutical ingredients
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing approval rate of wellness and preventive medicines
    • 5.1.3.2. Rapid growth of online pharmacies and improved availability through online platforms
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with abuse and misuse of consumer healthcare products
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Consumer Healthcare Market, by Product

• 6.1. Introduction
• 6.2. Dietary Supplements
• 6.3. OTC Pharmaceuticals

7. Consumer Healthcare Market, by Distribution

• 7.1. Introduction
• 7.2. Departmental Stores
• 7.3. Independent Retailers
• 7.4. Pharmacies or Drugstores
• 7.5. Specialist Retailers
• 7.6. Supermarkets or Hypermarkets

8. Americas Consumer Healthcare Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Consumer Healthcare Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Consumer Healthcare Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. SPE Capital acquires majority stake in Vital, the leading nutritional supplements company in Tunisia
  • 11.3.2. Nutrilitius expands portfolio with launch of new range of nutraceuticals, Unleashing the Power of Food Science & Technology
  • 11.3.3. LBB Specialties and DSM announce partnership for North America Dietary Supplements Distribution
  • 11.3.4. Cosmos Health to Launch Sky Premium Life Nutritional Supplement Products in Germany and Austria via Amazon and Ebay
  • 11.3.5. health supplements: Tata Consumer enters health supplements segment, launches plant protein powder
  • 11.3.6. Cipla Health to buy nutritional supplement brand Endura Mass
  • 11.3.7. Orkla Health acquires Healthspan
  • 11.3.8. Amway India launches nutrition supplements in gummies and jelly strips
  • 11.3.9. Wellbeing Nutrition raises $2.2 million led by Fireside Ventures
  • 11.3.10. Bayer launches Consumer Health division in India
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories Inc.
• 2. Alembic Pharmaceuticals Ltd.
• 3. Alkem Laboratories Limited
• 4. AMCO Proteins
• 5. American Health Inc.
• 6. Amway Corporation by Alticor corporation
• 7. Axtria Inc.
• 8. BASF SE
• 9. Bayer AG
• 10. Bionova Lifesciences by Pragati Biocare Pvt. Ltd.
• 11. Boehringer Ingelheim International GmbH
• 12. Cipla, Inc.
• 13. Dr. Reddy's Laboratories
• 14. Eli Lilly and Company
• 15. Endo Pharmaceuticals PLC by DuPont de Nemours, Inc.
• 16. Gemini Pharmaceuticals Inc.
• 17. Glanbia PLC
• 18. GlaxoSmithKline PLC
• 19. Glenmark Pharmaceuticals Ltd.
• 20. Henin Lukinz Pvt. Ltd.
• 21. Herbalife Ltd.
• 22. Hetero Drugs Ltd.
• 23. Himalaya Wellness Company
• 24. Iovate Health Sciences International Inc.
• 25. Ipsen S.A.
• 26. Johnson & Johnson Services, Inc.
• 27. Koninklijke DSM N.V.
• 28. Lonza Group Ltd.
• 29. Lupin Limited
• 30. Mankind Pharma
• 31. MusclePharm Corporation
• 32. Mylan Pharmaceuticals Pvt. Ltd. by Viatris
• 33. Nature's Bounty, Inc. by Nestle S.A.
• 34. Novartis AG
• 35. Omega Protein Corporation
• 36. Pfizer Inc.
• 37. Piramal Group
• 38. Procter & Gamble Company
• 39. PureTek Corporation
• 40. QuestNutrition
• 41. Reckitt Benckiser Group PLC
• 42. Sanofi S.A.
• 43. Sun Pharmaceutical Industries Limited
• 44. Takeda Pharmaceutical Company Limited
• 45. Teva Pharmaceutical Industries Ltd.
• 46. Ventus Pharmaceuticals Private Limited
• 47. Zoic Biotech Private Limited